ReviewJournal of clinical practice and research2024
Perioperative Acute Kidney Injury and Anesthesia: A Narrative Review.
Review in Journal of clinical practice and research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- A Dynamic Approach to Assessing and Predicting AKI Risk in Patients with Aortoiliac Occlusive Disease Undergoing Aorto-Bifemoral Bypass.Diagnostics (Basel, Switzerland) · 2026Article
- A Dynamic Online Nomogram for Predicting Postoperative Acute Kidney Injury After Sleeve Gastrectomy.Medical science monitor : international medical journal of experimental and clinical research · 2026Article
- Pathological triad of perioperative acute kidney injury: renal microcirculatory hypoxia, mitochondrial damage, and immuno-metabolic reprogramming.Frontiers in immunology · 2026Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Perioperative acute kidney injury (AKI) remains challenging for the anesthesiologist and surgeon. It is one of the most common, heterogeneous, and severe complications. Perioperative AKI is associated with increased morbidity, mortality, the need for renal replacement therapy (RRT), prolonged hospital stays, and escalating costs and healthcare resource utilization. Concomitant comorbidities, age, size, type, timing, the urgency of surgery, improper fluid management, anemia, hyperglycemia, malnutrition, the use of blood and blood products, contrast dyes, diuretics, and exposure to nephrotoxins are the main factors in the development of AKI. The main factors involved in the pathogenesis of perioperative AKI are highly complex and include a combination of hypoperfusion, microcirculatory and endothelial dysfunction, inflammation, and tubular cell damage. The main aim of anesthesiologists should be to identify risk factors in the perioperative period and minimize the incidence of perioperative AKI through appropriate anesthesia management and the necessary protective and preventive strategies. The anesthesia management should include optimization of hemodynamics, adequate organ perfusion and oxygenation, suitable monitoring, correct fluid management, anesthesia, pain control, mechanical ventilation methods, glycemic control, avoiding nephrotoxic drugs, contrast dyes, and blood transfusions, and early RRT and nutritional support. New biomarkers should be used to detect, intervene, and treat AKI promptly. We review the recent literature on the value and importance of comprehensive preoperative evaluation, optimization of risk factors, perioperative monitoring, anesthesia and pain management, preventive methods, and treatment in patients with AKI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.